478 related articles for article (PubMed ID: 27495223)
1. MicroRNA-451 Negatively Regulates Hepatic Glucose Production and Glucose Homeostasis by Targeting Glycerol Kinase-Mediated Gluconeogenesis.
Zhuo S; Yang M; Zhao Y; Chen X; Zhang F; Li N; Yao P; Zhu T; Mei H; Wang S; Li Y; Chen S; Le Y
Diabetes; 2016 Nov; 65(11):3276-3288. PubMed ID: 27495223
[TBL] [Abstract][Full Text] [Related]
2. MicroRNA-21 regulates hepatic glucose metabolism by targeting FOXO1.
Luo A; Yan H; Liang J; Du C; Zhao X; Sun L; Chen Y
Gene; 2017 Sep; 627():194-201. PubMed ID: 28627440
[TBL] [Abstract][Full Text] [Related]
3. Irisin inhibits hepatic gluconeogenesis and increases glycogen synthesis via the PI3K/Akt pathway in type 2 diabetic mice and hepatocytes.
Liu TY; Shi CX; Gao R; Sun HJ; Xiong XQ; Ding L; Chen Q; Li YH; Wang JJ; Kang YM; Zhu GQ
Clin Sci (Lond); 2015 Nov; 129(10):839-50. PubMed ID: 26201094
[TBL] [Abstract][Full Text] [Related]
4. Micro-RNA-27a/b negatively regulates hepatic gluconeogenesis by targeting FOXO1.
Wang S; Ai H; Liu L; Zhang X; Gao F; Zheng L; Yi J; Sun L; Yu C; Zhao H; Li Y
Am J Physiol Endocrinol Metab; 2019 Nov; 317(5):E911-E924. PubMed ID: 31526292
[TBL] [Abstract][Full Text] [Related]
5. MiR-19a mediates gluconeogenesis by targeting PTEN in hepatocytes.
Dou L; Wang S; Huang X; Sun X; Zhang Y; Shen T; Guo J; Man Y; Tang W; Li J
Mol Med Rep; 2018 Mar; 17(3):3967-3971. PubMed ID: 29257352
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-185-5p inhibits hepatic gluconeogenesis and reduces fasting blood glucose levels by suppressing G6Pase.
Zheng H; Wan J; Shan Y; Song X; Jin J; Su Q; Chen S; Lu X; Yang J; Li Q; Song Y; Li B
Theranostics; 2021; 11(16):7829-7843. PubMed ID: 34335967
[No Abstract] [Full Text] [Related]
7. Glycerol kinase interacts with nuclear receptor NR4A1 and regulates glucose metabolism in the liver.
Miao L; Yang Y; Liu Y; Lai L; Wang L; Zhan Y; Yin R; Yu M; Li C; Yang X; Ge C
FASEB J; 2019 Jun; 33(6):6736-6747. PubMed ID: 30821173
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-351 eases insulin resistance and liver gluconeogenesis via the PI3K/AKT pathway by inhibiting FLOT2 in mice of gestational diabetes mellitus.
Chen SH; Liu XN; Peng Y
J Cell Mol Med; 2019 Sep; 23(9):5895-5906. PubMed ID: 31287224
[TBL] [Abstract][Full Text] [Related]
9. A decrease in hepatic microRNA-9 expression impairs gluconeogenesis by targeting FOXO1 in obese mice.
Yan C; Chen J; Li M; Xuan W; Su D; You H; Huang Y; Chen N; Liang X
Diabetologia; 2016 Jul; 59(7):1524-1532. PubMed ID: 27003684
[TBL] [Abstract][Full Text] [Related]
10. Hepatic NPC1L1 overexpression ameliorates glucose metabolism in diabetic mice via suppression of gluconeogenesis.
Kurano M; Hara M; Satoh H; Tsukamoto K
Metabolism; 2015 May; 64(5):588-96. PubMed ID: 25660144
[TBL] [Abstract][Full Text] [Related]
11. GdCl3 reduces hyperglycaemia through Akt/FoxO1-induced suppression of hepatic gluconeogenesis in Type 2 diabetic mice.
Wang Q; Wang N; Dong M; Chen F; Li Z; Chen Y
Clin Sci (Lond); 2014 Jul; 127(2):91-100. PubMed ID: 24444370
[TBL] [Abstract][Full Text] [Related]
12. Evodia alkaloids suppress gluconeogenesis and lipogenesis by activating the constitutive androstane receptor.
Yu L; Wang Z; Huang M; Li Y; Zeng K; Lei J; Hu H; Chen B; Lu J; Xie W; Zeng S
Biochim Biophys Acta; 2016 Sep; 1859(9):1100-1111. PubMed ID: 26455953
[TBL] [Abstract][Full Text] [Related]
13. Sodium meta-arsenite ameliorates hyperglycemia in obese diabetic db/db mice by inhibition of hepatic gluconeogenesis.
Lee YS; Lee EK; Oh HH; Choi CS; Kim S; Jun HS
J Diabetes Res; 2014; 2014():961732. PubMed ID: 25610880
[TBL] [Abstract][Full Text] [Related]
14. CREB-upregulated lncRNA MEG3 promotes hepatic gluconeogenesis by regulating miR-302a-3p-CRTC2 axis.
Zhu X; Li H; Wu Y; Zhou J; Yang G; Wang W; Kang D; Ye S
J Cell Biochem; 2019 Mar; 120(3):4192-4202. PubMed ID: 30260029
[TBL] [Abstract][Full Text] [Related]
15. lncRNA MEG3 promotes hepatic insulin resistance by serving as a competing endogenous RNA of miR-214 to regulate ATF4 expression.
Zhu X; Li H; Wu Y; Zhou J; Yang G; Wang W
Int J Mol Med; 2019 Jan; 43(1):345-357. PubMed ID: 30431065
[TBL] [Abstract][Full Text] [Related]
16. Circular RNA HIPK3 contributes to hyperglycemia and insulin homeostasis by sponging miR-192-5p and upregulating transcription factor forkhead box O1.
Cai H; Jiang Z; Yang X; Lin J; Cai Q; Li X
Endocr J; 2020 Apr; 67(4):397-408. PubMed ID: 31875589
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of gluconeogenesis in primary hepatocytes by stromal cell-derived factor-1 (SDF-1) through a c-Src/Akt-dependent signaling pathway.
Liu HY; Wen GB; Han J; Hong T; Zhuo D; Liu Z; Cao W
J Biol Chem; 2008 Nov; 283(45):30642-9. PubMed ID: 18786922
[TBL] [Abstract][Full Text] [Related]
18. MicroRNA-29a-c decrease fasting blood glucose levels by negatively regulating hepatic gluconeogenesis.
Liang J; Liu C; Qiao A; Cui Y; Zhang H; Cui A; Zhang S; Yang Y; Xiao X; Chen Y; Fang F; Chang Y
J Hepatol; 2013 Mar; 58(3):535-42. PubMed ID: 23111009
[TBL] [Abstract][Full Text] [Related]
19. Type I neuregulin1α is a novel local mediator to suppress hepatic gluconeogenesis in mice.
Arai T; Ono Y; Arimura Y; Sayama K; Suzuki T; Shinjo S; Kanai M; Abe SI; Semba K; Goda N
Sci Rep; 2017 Feb; 7():42959. PubMed ID: 28218289
[TBL] [Abstract][Full Text] [Related]
20. Regulation of insulin resistance by targeting the insulin-like growth factor 1 receptor with microRNA-122-5p in hepatic cells.
Dong L; Hou X; Liu F; Tao H; Zhang Y; Zhao H; Song G
Cell Biol Int; 2019 May; 43(5):553-564. PubMed ID: 30958584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]